Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017

C Hiemke, N Bergemann, HW Clement… - …, 2018 - thieme-connect.com
Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug
concentrations in blood to optimize pharmacotherapy. It considers the interindividual …

Ziprasidone versus other atypical antipsychotics for schizophrenia

K Komossa, C Rummel‐Kluge… - Cochrane Database …, 2009 - cochranelibrary.com
Background In many countries of the industrialised world second generation ('atypical')
antipsychotics have become the first line drug treatment for people with schizophrenia. The …

Addressing structural racism in psychiatry with steps to improve psychophysiologic research

JL Price, MA Bruce, B Adinoff - JAMA psychiatry, 2022 - jamanetwork.com
Importance The American Medical Association has acknowledged the public health threat
posed by racism in medicine. While clinicians in psychiatry have echoed the sentiment, the …

Nicotine and Opioids: a Call for Co-treatment as the Standard of Care

CD Morris, CE Garver-Apgar - The journal of behavioral health services & …, 2020 - Springer
The US is in the midst of an opioid epidemic. At the same time, tobacco use remains the
leading cause of preventable death and disability. While the shared biological …

Perphenazine for schizophrenia

B Hartung, S Sampson… - Cochrane database of …, 2015 - cochranelibrary.com
Background Perphenazine is an old phenothiazine antipsychotic with a potency similar to
haloperidol. It has been used for many years and is popular in the northern European …

Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations

C Bustamante, R Ochoa, C Asela, C Muskus - Journal of Computer-Aided …, 2019 - Springer
Leishmaniasis is a neglected tropical disease caused by Leishmania parasites and is
associated to more than 1.3 million cases annually. Some of the pharmacological options for …

Impact of CYP2D6 on serum concentrations of flupentixol, haloperidol, perphenazine and zuclopenthixol

RB Waade, V Solhaug, G Høiseth - British Journal of Clinical …, 2021 - Wiley Online Library
Aims To investigate the impact of cytochrome P450 2D6 (CYP2D6) on dose‐adjusted serum
concentrations of flupentixol, haloperidol, perphenazine and zuclopenthixol in a therapeutic …

Electrospun fibers as potential carrier systems for enhanced drug release of perphenazine

G Bruni, L Maggi, L Tammaro, R Di Lorenzo… - International journal of …, 2016 - Elsevier
Solubility represents an important challenge for formulation of drugs, because the
therapeutic efficacy of a drug depends on the bioavailability and ultimately on its solubility …

Effect of smoking on risperidone pharmacokinetics–a multifactorial approach to better predict the influence on drug metabolism

G Schoretsanitis, E Haen, B Stegmann, C Hiemke… - Schizophrenia …, 2017 - Elsevier
Purpose To disentangle an association between tobacco smoking, smoking habits and
pharmacokinetic patterns such as plasma concentrations of risperidone (RIS), its active …

Comparison of Efficacy and Safety between Long‐Acting Injectable Antipsychotic Monotherapy and Combination of Long‐Acting Injectable and Oral Antipsychotics in …

T Sathienluckana, P Tiangpattanawong… - Schizophrenia …, 2021 - Wiley Online Library
Background. Long‐acting injectable (LAI) antipsychotics are used as a monotherapy in
patients with schizophrenia. However, the combination of LAI and oral antipsychotics is …